GYRE logo

Gyre Therapeutics Inc

GYRE

$24.87

+ $8.19 (56.37%) This month

Closed: 27 Feb 2024 21:00 US/Eastern

Key details

CEO

Nassim Usman

Employees

35

Headquarters

South San Francisco, US

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

About Gyre Therapeutics Inc

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG